skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index

Results 21 - 40 of 22,129  for All Library Resources

Sorted by: Sorted by: RelevanceOr hit Enter to replace sort method
previous page 1 Results 2 3 4 5 next page
Refined by: subject: Female remove subject: Patients remove
Result Number Material Type Add to My Shelf Action Record Details and Options
21
Real world heart failure epidemiology and outcome: A population-based analysis of 88,195 patients
Real world heart failure epidemiology and outcome: A population-based analysis of 88,195 patients
Material Type:
Article 		Add to My Research

Real world heart failure epidemiology and outcome: A population-based analysis of 88,195 patients

PloS one, 2017-02, Vol.12 (2), p.e0172745-e0172745 [Peer Reviewed Journal]

COPYRIGHT 2017 Public Library of Science ;COPYRIGHT 2017 Public Library of Science ;2017 Farré et al. This is an open access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;cc-by (c) Farré et al., 2017 info:eu-repo/semantics/openAccess http://creativecommons.org/licenses/by/3.0/es ;2017 Farré et al 2017 Farré et al ;ISSN: 1932-6203 ;EISSN: 1932-6203 ;DOI: 10.1371/journal.pone.0172745 ;PMID: 28235067

Full text available

Citations Cited by
22
Features of 20 133 UK patients in hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: prospective observational cohort study
Features of 20 133 UK patients in hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: prospective observational cohort study
Material Type:
Article 		Add to My Research

Features of 20 133 UK patients in hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: prospective observational cohort study

BMJ, 2020-05, Vol.369, p.m1985-m1985 [Peer Reviewed Journal]

Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY. No commercial re-use. See rights and permissions. Published by BMJ. ;Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY. No commercial re-use. See rights and permissions. Published by BMJ. ;2020. This work is published under http://creativecommons.org/licenses/by/4.0 (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2020 Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY. No commercial re-use. See rights and permissions. Published by BMJ. BMJ This is an Open Access article distributed in accordance with the terms of the Creative Commons Attribution (CC BY 4.0) license, which permits others to distribute, remix, adapt and build upon this work, for commercial use, provided the original work is properly cited. See: http://creativecommons.org/licenses/by/4.0/ . Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY. No commercial re-use. See rights and permissions. Published by BMJ. 2020 BMJ ;ISSN: 1756-1833 ;ISSN: 0959-8138 ;EISSN: 1756-1833 ;DOI: 10.1136/bmj.m1985 ;PMID: 32444460

Digital Resources/Online E-Resources

Citations Cited by
23
Serum circulating microRNA profiling for identification of potential type 2 diabetes and obesity biomarkers
Serum circulating microRNA profiling for identification of potential type 2 diabetes and obesity biomarkers
Material Type:
Article 		Add to My Research

Serum circulating microRNA profiling for identification of potential type 2 diabetes and obesity biomarkers

PloS one, 2013-10, Vol.8 (10), p.e77251-e77251 [Peer Reviewed Journal]

COPYRIGHT 2013 Public Library of Science ;COPYRIGHT 2013 Public Library of Science ;2013 Pescador et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License: https://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2013 Pescador et al 2013 Pescador et al ;ISSN: 1932-6203 ;EISSN: 1932-6203 ;DOI: 10.1371/journal.pone.0077251 ;PMID: 24204780

Full text available

Citations Cited by
24
Effect of early intensive multifactorial therapy on 5-year cardiovascular outcomes in individuals with type 2 diabetes detected by screening (ADDITION-Europe): a cluster-randomised trial
Effect of early intensive multifactorial therapy on 5-year cardiovascular outcomes in individuals with type 2 diabetes detected by screening (ADDITION-Europe): a cluster-randomised trial
Material Type:
Article 		Add to My Research

Effect of early intensive multifactorial therapy on 5-year cardiovascular outcomes in individuals with type 2 diabetes detected by screening (ADDITION-Europe): a cluster-randomised trial

The Lancet (British edition), 2011-07, Vol.378 (9786), p.156-167 [Peer Reviewed Journal]

Elsevier Ltd ;2011 Elsevier Ltd ;2015 INIST-CNRS ;Copyright © 2011 Elsevier Ltd. All rights reserved. ;Copyright Elsevier Limited Jul 9-Jul 15, 2011 ;2011 Elsevier Ltd. All rights reserved. 2011 Elsevier Ltd ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(11)60698-3 ;PMID: 21705063 ;CODEN: LANCAO

Full text available

Citations Cited by
25
Association of tumour mutational burden with outcomes in patients with advanced solid tumours treated with pembrolizumab: prospective biomarker analysis of the multicohort, open-label, phase 2 KEYNOTE-158 study
Association of tumour mutational burden with outcomes in patients with advanced solid tumours treated with pembrolizumab: prospective biomarker analysis of the multicohort, open-label, phase 2 KEYNOTE-158 study
Material Type:
Article 		Add to My Research

Association of tumour mutational burden with outcomes in patients with advanced solid tumours treated with pembrolizumab: prospective biomarker analysis of the multicohort, open-label, phase 2 KEYNOTE-158 study

The lancet oncology, 2020-10, Vol.21 (10), p.1353-1365 [Peer Reviewed Journal]

2020 Elsevier Ltd ;Copyright © 2020 Elsevier Ltd. All rights reserved. ;2020. Elsevier Ltd ;ISSN: 1470-2045 ;EISSN: 1474-5488 ;DOI: 10.1016/S1470-2045(20)30445-9 ;PMID: 32919526

Full text available

Citations Cited by
26
Colchicine in Patients with Chronic Coronary Disease
Colchicine in Patients with Chronic Coronary Disease
Material Type:
Article 		Add to My Research

Colchicine in Patients with Chronic Coronary Disease

The New England journal of medicine, 2020-11, Vol.383 (19), p.1838-1847 [Peer Reviewed Journal]

Copyright © 2020 Massachusetts Medical Society. All rights reserved. ;Copyright © 2020 Massachusetts Medical Society. ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa2021372 ;PMID: 32865380

Full text available

Citations Cited by
27
1-year outcomes in hospital survivors with COVID-19: a longitudinal cohort study
1-year outcomes in hospital survivors with COVID-19: a longitudinal cohort study
Material Type:
Article 		Add to My Research

1-year outcomes in hospital survivors with COVID-19: a longitudinal cohort study

The Lancet (British edition), 2021-08, Vol.398 (10302), p.747-758 [Peer Reviewed Journal]

2021 Elsevier Ltd ;Copyright © 2021 Elsevier Ltd. All rights reserved. ;2021. Elsevier Ltd ;2021 Elsevier Ltd. All rights reserved. 2021 Elsevier Ltd ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(21)01755-4 ;PMID: 34454673

Full text available

Citations Cited by
28
Predicting future clinical changes of MCI patients using longitudinal and multimodal biomarkers
Predicting future clinical changes of MCI patients using longitudinal and multimodal biomarkers
Material Type:
Article 		Add to My Research

Predicting future clinical changes of MCI patients using longitudinal and multimodal biomarkers

PloS one, 2012-03, Vol.7 (3), p.e33182-e33182 [Peer Reviewed Journal]

COPYRIGHT 2012 Public Library of Science ;COPYRIGHT 2012 Public Library of Science ;2012 Zhang et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License: https://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;Zhang et al. 2012 ;ISSN: 1932-6203 ;EISSN: 1932-6203 ;DOI: 10.1371/journal.pone.0033182 ;PMID: 22457741

Full text available

Citations Cited by
29
Hospital admission and emergency care attendance risk for SARS-CoV-2 delta (B.1.617.2) compared with alpha (B.1.1.7) variants of concern: a cohort study
Hospital admission and emergency care attendance risk for SARS-CoV-2 delta (B.1.617.2) compared with alpha (B.1.1.7) variants of concern: a cohort study
Material Type:
Article 		Add to My Research

Hospital admission and emergency care attendance risk for SARS-CoV-2 delta (B.1.617.2) compared with alpha (B.1.1.7) variants of concern: a cohort study

The Lancet infectious diseases, 2022-01, Vol.22 (1), p.35-42 [Peer Reviewed Journal]

2022 ;Crown copyright © 2022 Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license. ;Copyright Elsevier Limited Jan 2022 ;Crown Copyright © 2021 Published by Elsevier Ltd. 2022 ;ISSN: 1473-3099 ;EISSN: 1474-4457 ;DOI: 10.1016/S1473-3099(21)00475-8 ;PMID: 34461056

Full text available

Citations Cited by
30
GDF-15 Is Elevated in Children with Mitochondrial Diseases and Is Induced by Mitochondrial Dysfunction
GDF-15 Is Elevated in Children with Mitochondrial Diseases and Is Induced by Mitochondrial Dysfunction
Material Type:
Article 		Add to My Research

GDF-15 Is Elevated in Children with Mitochondrial Diseases and Is Induced by Mitochondrial Dysfunction

PloS one, 2016-02, Vol.11 (2), p.e0148709-e0148709 [Peer Reviewed Journal]

COPYRIGHT 2016 Public Library of Science ;COPYRIGHT 2016 Public Library of Science ;2016 Montero et al. This is an open access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;cc-by (c) Montero, Raquel et al., 2016 info:eu-repo/semantics/openAccess http://creativecommons.org/licenses/by/3.0/es ;2016 Montero et al 2016 Montero et al ;ISSN: 1932-6203 ;EISSN: 1932-6203 ;DOI: 10.1371/journal.pone.0148709 ;PMID: 26867126

Full text available

Citations Cited by
31
Safety and efficacy of dalcetrapib on atherosclerotic disease using novel non-invasive multimodality imaging (dal-PLAQUE): a randomised clinical trial
Safety and efficacy of dalcetrapib on atherosclerotic disease using novel non-invasive multimodality imaging (dal-PLAQUE): a randomised clinical trial
Material Type:
Article 		Add to My Research

Safety and efficacy of dalcetrapib on atherosclerotic disease using novel non-invasive multimodality imaging (dal-PLAQUE): a randomised clinical trial

The Lancet (British edition), 2011-10, Vol.378 (9802), p.1547-1559 [Peer Reviewed Journal]

Elsevier Ltd ;2011 Elsevier Ltd ;2015 INIST-CNRS ;Copyright © 2011 Elsevier Ltd. All rights reserved. ;Copyright Elsevier Limited Oct 29-Nov 4, 2011 ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(11)61383-4 ;PMID: 21908036 ;CODEN: LANCAO

Full text available

Citations Cited by
32
Bamlanivimab plus Etesevimab in Mild or Moderate Covid-19
Bamlanivimab plus Etesevimab in Mild or Moderate Covid-19
Material Type:
Article 		Add to My Research

Bamlanivimab plus Etesevimab in Mild or Moderate Covid-19

New England Journal of Medicine, 2021-10, Vol.385 (15), p.1382-1392 [Peer Reviewed Journal]

Copyright © 2021 Massachusetts Medical Society. All rights reserved. ;Copyright © 2021 Massachusetts Medical Society. ;COPYRIGHT 2021 Massachusetts Medical Society ;2021. Not withstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at https://www.nejm.org/about-nejm/permissions?query=footer ;Copyright © 2021 Massachusetts Medical Society. All rights reserved. 2021 Massachusetts Medical Society ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa2102685 ;PMID: 34260849

Digital Resources/Online E-Resources

Citations Cited by
33
Reduced mortality and subsequent fracture risk associated with oral bisphosphonate recommendation in a fracture liaison service setting: A prospective cohort study
Reduced mortality and subsequent fracture risk associated with oral bisphosphonate recommendation in a fracture liaison service setting: A prospective cohort study
Material Type:
Article 		Add to My Research

Reduced mortality and subsequent fracture risk associated with oral bisphosphonate recommendation in a fracture liaison service setting: A prospective cohort study

PloS one, 2018-06, Vol.13 (6), p.e0198006-e0198006 [Peer Reviewed Journal]

COPYRIGHT 2018 Public Library of Science ;COPYRIGHT 2018 Public Library of Science ;2018 van Geel et al. This is an open access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2018 van Geel et al 2018 van Geel et al ;ISSN: 1932-6203 ;EISSN: 1932-6203 ;DOI: 10.1371/journal.pone.0198006 ;PMID: 29856795

Full text available

Citations Cited by
34
Trastuzumab for early-stage, HER2-positive breast cancer: a meta-analysis of 13 864 women in seven randomised trials
Trastuzumab for early-stage, HER2-positive breast cancer: a meta-analysis of 13 864 women in seven randomised trials
Material Type:
Article 		Add to My Research

Trastuzumab for early-stage, HER2-positive breast cancer: a meta-analysis of 13 864 women in seven randomised trials

The lancet oncology, 2021-08, Vol.22 (8), p.1139-1150 [Peer Reviewed Journal]

2021 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license ;Copyright © 2021 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license. Published by Elsevier Ltd.. All rights reserved. ;2021. The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license. This work is published under https://creativecommons.org/licenses/by/3.0/ (theLicense”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2021 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license 2021 ;ISSN: 1470-2045 ;ISSN: 1474-5488 ;EISSN: 1474-5488 ;DOI: 10.1016/S1470-2045(21)00288-6 ;PMID: 34339645

Full text available

Citations Cited by
35
Stereotactic ablative radiotherapy versus standard of care palliative treatment in patients with oligometastatic cancers (SABR-COMET): a randomised, phase 2, open-label trial
Stereotactic ablative radiotherapy versus standard of care palliative treatment in patients with oligometastatic cancers (SABR-COMET): a randomised, phase 2, open-label trial
Material Type:
Article 		Add to My Research

Stereotactic ablative radiotherapy versus standard of care palliative treatment in patients with oligometastatic cancers (SABR-COMET): a randomised, phase 2, open-label trial

The Lancet (British edition), 2019-05, Vol.393 (10185), p.2051-2058 [Peer Reviewed Journal]

2019 Elsevier Ltd ;Copyright © 2019 Elsevier Ltd. All rights reserved. ;2019. Elsevier Ltd ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(18)32487-5 ;PMID: 30982687

Full text available

Citations Cited by
36
A Dataset for Breast Cancer Histopathological Image Classification
A Dataset for Breast Cancer Histopathological Image Classification
Material Type:
Article 		Add to My Research

A Dataset for Breast Cancer Histopathological Image Classification

IEEE transactions on biomedical engineering, 2016-07, Vol.63 (7), p.1455 [Peer Reviewed Journal]

EISSN: 1558-2531 ;DOI: 10.1109/tbme.2015.2496264 ;PMID: 26540668

Digital Resources/Online E-Resources

Citations Cited by
37
The American Headache Society Position Statement On Integrating New Migraine Treatments Into Clinical Practice
The American Headache Society Position Statement On Integrating New Migraine Treatments Into Clinical Practice
Material Type:
Article 		Add to My Research

The American Headache Society Position Statement On Integrating New Migraine Treatments Into Clinical Practice

Headache, 2019-01, Vol.59 (1), p.1 [Peer Reviewed Journal]

2018 American Headache Society. ;EISSN: 1526-4610 ;DOI: 10.1111/head.13456 ;PMID: 30536394

Digital Resources/Online E-Resources

Citations Cited by
38
Hypofractionated breast radiotherapy for 1 week versus 3 weeks (FAST-Forward): 5-year efficacy and late normal tissue effects results from a multicentre, non-inferiority, randomised, phase 3 trial
Hypofractionated breast radiotherapy for 1 week versus 3 weeks (FAST-Forward): 5-year efficacy and late normal tissue effects results from a multicentre, non-inferiority, randomised, phase 3 trial
Material Type:
Article 		Add to My Research

Hypofractionated breast radiotherapy for 1 week versus 3 weeks (FAST-Forward): 5-year efficacy and late normal tissue effects results from a multicentre, non-inferiority, randomised, phase 3 trial

The Lancet (British edition), 2020-05, Vol.395 (10237), p.1613-1626 [Peer Reviewed Journal]

2020 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license ;Copyright © 2020 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license. Published by Elsevier Ltd.. All rights reserved. ;2020. The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license. This work is published under https://creativecommons.org/licenses/by/3.0/ (theLicense”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2020 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license 2020 ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(20)30932-6 ;PMID: 32580883

Full text available

Citations Cited by
39
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
Material Type:
Article 		Add to My Research

Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China

The Lancet, 2020-02, Vol.395 (10223), p.497-506 [Peer Reviewed Journal]

2020 Elsevier Ltd ;Copyright © 2020 Elsevier Ltd. All rights reserved. ;2020. Elsevier Ltd ;2020. Not withstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at https://www.elsevier.com/legal/elsevier-website-terms-and-conditions ;2020 Elsevier Ltd. All rights reserved. 2020 Elsevier Ltd ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(20)30183-5 ;PMID: 31986264

Digital Resources/Online E-Resources

Citations Cited by
40
Adjuvant Chemotherapy Guided by a 21-Gene Expression Assay in Breast Cancer
Adjuvant Chemotherapy Guided by a 21-Gene Expression Assay in Breast Cancer
Material Type:
Article 		Add to My Research

Adjuvant Chemotherapy Guided by a 21-Gene Expression Assay in Breast Cancer

The New England journal of medicine, 2018-07, Vol.379 (2), p.111-121 [Peer Reviewed Journal]

Copyright © 2018 Massachusetts Medical Society. All rights reserved. ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa1804710 ;PMID: 29860917

Full text available

Citations Cited by

Results 21 - 40 of 22,129  for All Library Resources

Sorted by: Sorted by: RelevanceOr hit Enter to replace sort method
previous page 1 Results 2 3 4 5 next page

Personalize your results

  1. Edit

Refine Search Results

Expand My Results

  1.   

Refine My Results

Creation Date 

From To
Refine
  1. Before 1986  (27)
  2. 1986 To 1994  (382)
  3. 1995 To 2003  (457)
  4. 2004 To 2013  (5,372)
  5. After 2013  (15,892)
  6. More options open sub menu

Resource Type 

  1. Articles  (22,110)
  2. magazinearticle  (16)
  3. Newsletter Articles  (3)
  4. More options open sub menu

Subject 

  1. Humans  (22,043)
  2. Medical Research  (21,471)
  3. Science & Technology  (21,185)
  4. Male  (19,192)
  5. Middle Aged  (15,051)
  6. Life Sciences & Biomedicine  (13,926)
  7. Adult  (12,133)
  8. Aged  (11,548)
  9. Medicine, Experimental  (10,449)
  10. Science & Technology - Other Topics  (7,247)
  11. Multidisciplinary Sciences  (7,243)
  12. Hospitals  (5,805)
  13. Medicine  (5,780)
  14. Analysis  (5,686)
  15. Care And Treatment  (5,488)
  16. Studies  (5,046)
  17. Health Aspects  (4,581)
  18. Risk Factors  (4,545)
  19. More options open sub menu

Language 

  1. English  (22,127)
  2. Japanese  (2,590)
  3. Portuguese  (50)
  4. Norwegian  (35)
  5. French  (15)
  6. Persian  (7)
  7. Chinese  (6)
  8. Turkish  (4)
  9. Spanish  (4)
  10. Russian  (2)
  11. Arabic  (2)
  12. Dutch  (2)
  13. More options open sub menu
INSPIRE LIBRARY - TON DUC THANG UNIVERSITY (84-028) 37 755 057 Feedback
19 Nguyen Huu Tho St. Dist.7, HCM thuvien@tdtu.edu.vn

Copyright © 2017 INSPIRE LIBRARY - TON DUC THANG UNIVERSITY

Searching Remote Databases, Please Wait